Glaucoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
====Prevalence====
====Prevalence====
*The global prevalence of glaucoma for population aged 40–80 years is 3.54% (95% Confidence Interval, 2.09–5.82). The prevalence of POAG is highest in Africa - 4.20% (95% Confidence Interval, 2.08–7.35). In 2013, the number of people (aged 40–80 years) with glaucoma worldwide was estimated to be 64.3 million, increasing to 76.0 million in 2020 and 111.8 million in 2040.  
*The global prevalence of glaucoma for population aged 40–80 years is 3.54% (95% Confidence Interval, 2.09–5.82). The prevalence of POAG is highest in Africa - 4.20% (95% Confidence Interval, 2.08–7.35). In 2013, the number of people (aged 40–80 years) with glaucoma worldwide was estimated to be 64.3 million, increasing to 76.0 million in 2020 and 111.8 million in 2040.<ref name="ISSN 0161-6420">{{cite journal| author= Yih-Chung Tham, Xiang Li, Tien Y. Wong, Harry A. Quigley, Tin Aung, Ching-Yu Cheng | title= Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 | journal=Ophthalmology | year= 2014 | volume= 121 | issue= 11 | pages= 2081-2090 | pmid= | doi=10.1016/j.ophtha.2014.05.013  | pmc= | url=http://www.sciencedirect.com/science/article/pii/S0161642014004333 }}</ref>  
<ref name="ISSN 0161-6420">{{cite journal| author= Yih-Chung Tham, Xiang Li, Tien Y. Wong, Harry A. Quigley, Tin Aung, Ching-Yu Cheng | title= Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 | journal=Ophthalmology | year= 2014 | volume= 121 | issue= 11 | pages= 2081-2090 | pmid= | doi=10.1016/j.ophtha.2014.05.013  | pmc= | url=http://www.sciencedirect.com/science/article/pii/S0161642014004333 }}</ref>  
 
* Glaucoma affects one in two hundred people aged fifty and younger and one in ten over the age of eighty.
* Glaucoma affects one in two hundred people aged fifty and younger and one in ten over the age of eighty.
* Worldwide, it is the second leading cause of blindness.<ref>[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=606657 "Glaucoma, Normal Tension, Susceptibility To."] OMIM - Online Mendelian Inheritance in Man. Accessed October 17, 2006.</ref>  
* Worldwide, it is the second leading cause of blindness.<ref>[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=606657 "Glaucoma, Normal Tension, Susceptibility To."] OMIM - Online Mendelian Inheritance in Man. Accessed October 17, 2006.</ref>  

Revision as of 21:05, 24 June 2017

Glaucoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glaucoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glaucoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glaucoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glaucoma epidemiology and demographics

CDC on Glaucoma epidemiology and demographics

Glaucoma epidemiology and demographics in the news

Blogs on Glaucoma epidemiology and demographics

Directions to Hospitals Treating Glaucoma

Risk calculators and risk factors for Glaucoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Rohan Bir Singh, M.B.B.S.[2]

Epidemiology and Demographics

Prevalence

  • The global prevalence of glaucoma for population aged 40–80 years is 3.54% (95% Confidence Interval, 2.09–5.82). The prevalence of POAG is highest in Africa - 4.20% (95% Confidence Interval, 2.08–7.35). In 2013, the number of people (aged 40–80 years) with glaucoma worldwide was estimated to be 64.3 million, increasing to 76.0 million in 2020 and 111.8 million in 2040.[1]
  • Glaucoma affects one in two hundred people aged fifty and younger and one in ten over the age of eighty.
  • Worldwide, it is the second leading cause of blindness.[2]

Primary Open-Angle Glaucoma

The overall prevalence of OAG in the US population 40 years and older is estimated to be 1.86% (95% confidence interval, 1.75%-1.96%), with 1.57 million white and 398000 black persons affected. After applying race-, age-, and gender-specific rates to the US population as determined in the 2000 US census, it was estimated that OAG affects 2.22 million US citizens. Owing to the rapidly aging population, the number with OAG will increase by 50% to 3.36 million by 2020. [3]

Age

  • In Rotterdam and Barbados study, there is a significant increase in the prevalence of glaucoma in older individuals, with estimates for persons in their 70s being generally 3 to 8 times higher than those for persons in their 40s. In addition, multiple population-based surveys have demonstrated a higher prevalence of glaucoma in specific ethnic groups.

Gender

  • In the Bayesian meta-regression model, men were more likely to have POAG than women (odds ratio [OR], 1.36; 95% CrI, 1.23–1.52), and after adjusting for age, gender, habitation type, response rate, and year of study, people of African ancestry were more likely to have POAG than people of European ancestry (OR, 2.80; 95% CrI, 1.83–4.06), and people living in urban areas were more likely to have POAG than those in rural areas (OR, 1.58; 95% CrI, 1.19–2.04).[1]

Race

  • Among whites aged 40 years and older, a prevalence of between 1.1% and 2.1% has been reported based on population-based studies performed throughout the world.
  • The prevalence among black persons and Latino persons is up to 4 times higher compared to the prevalence among whites. Black individuals are also at greater risk of blindness from POAG, and this risk increases with age: in persons aged 46-65 years, the likelihood of blindness from POAG is 15 times higher among blacks than that among whites.

Primary Angle Closure Glaucoma

The prevalence of PACG is highest in Asia - 1.09%; (95% Confidence Interval, 0.43–2.32)[3]

References

  1. 1.0 1.1 Yih-Chung Tham, Xiang Li, Tien Y. Wong, Harry A. Quigley, Tin Aung, Ching-Yu Cheng (2014). "Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040". Ophthalmology. 121 (11): 2081–2090. doi:10.1016/j.ophtha.2014.05.013.
  2. "Glaucoma, Normal Tension, Susceptibility To." OMIM - Online Mendelian Inheritance in Man. Accessed October 17, 2006.
  3. 3.0 3.1 Friedman DS, Wolfs RC, O'Colmain BJ, Klein BE, Taylor HR, West S, Leske MC, Mitchell P, Congdon N, Kempen J, Eye Diseases Prevalence Research Group (2004). "Prevalence of Open-Angle Glaucoma Among Adults in the United States". Arch Ophthalmol. 122 (4): 532–8. doi:10.1001/archopht.122.4.532. PMC 2798086. PMID 15078671.

*

Template:WH Template:WS